Бастиан Блоэм - Нестареющее тело. Научное исследование о том, как защитить свои тело и мозг и не допустить развития неврологических заболеваний

И наконец, мы благодарим родных и друзей за то, что ободряли нас в этом непростом деле. Мы и наш труд – отражение всего того, что нас окружает. Родные были нашими самыми справедливыми и полезными критиками, они создали нам условия для работы и оказывали всяческую поддержку. К какой-то степени они тоже восстали против болезни Паркинсона. Мы бесконечно ценим и благодарим всех и каждого, в особенности наших жен: Зену, Келли, Лесли и Инге. Мы вас очень любим.

1. Dubos R. Mirage of Health: Utopias, Progress, and Biological Change. New York: Harper & Brothers; 1959.

2. Dorsey ER, Bloem BR. The Parkinson pandemic – a call to action. JAMA Neurology. 2018;75(1):9-10.

3. GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurology. 2017;16(11):877–897.

4. Dorsey ER, Bloem BR. The Parkinson pandemic – a call to action. JAMA Neurology. 2018;75(1):9-10.

5. Там же.

6. Ascherio A, Schwarzschild MA. The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurology. 2016;15(12):1257–1272; Goldman SM. Environmental toxins and Parkinson’s disease. Annual Review of Pharmacology and Toxicology. 2014;54(1): 141–164; Elbaz A, Carcaillon L, Kab S, Moisan F. Epidemiology of Parkinson’s disease. Revue Neurologique. 2016;172(1):14–26.

7. Shulman LM, Katzel LI, Ivey FM, et al. Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease. JAMA Neurology. 2013;70(2):183–190; Rosenthal LS, Dorsey ER. The benefits of exercise in Parkinson disease. JAMA Neurology . 2013;70(2): 156–157; Li F, Harmer P, Fitzgerald K, et al. Tai chi and postural stability in patients with Parkinson’s disease. New England Journal of Medicine. 2012;366(6):511–519.

8. Goldman SM. Environmental toxins and Parkinson’s disease. Annual Review of Pharmacology and Toxicology. 2014;54(1):141–164; Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson’s disease. New England Journal of Medicine. 2006;355(9):896–908.

9. Factor SA, Feustel PJ, Friedman JH, et al. Longitudinal outcome of Parkinson’s disease patients with psychosis. Neurology . 2003;60(11):1756–1761; Parashos SA, Maraganore DM, O’Brien PC, Rocca WA. Medical services utilization and prognosis in Parkinson disease: a population-based study. Mayo Clinic Proceedings . 2002;77(9):918–925; Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Caregiver-burden in Parkinson’s disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism & Related Disorders. 2006;12(1):35–41; Aarsland D, Larsen JP, Karlsen K, Lim NG, Tandberg E. Mental symptoms in Parkinson’s disease are important contributors to caregiver distress. International Journal of Geriatric Psychiatry . 1999;14(10):866–874.

10. Buter TC, van den Hout A, Matthews FE, Larsen JP, Brayne C, Aarsland D. Dementia and survival in Parkinson disease: a 12-year population study. Neurology. 2008;70(13):1017–1022; Beyer MK, Herlofson K, Aarsland D, Larsen JP. Causes of death in a community-based study of Parkinson’s disease. Acta Neurologica Scandinavica. 2001;103(1):7-11; Fall PA, Saleh A, Fredrickson M, Olsson J-E, Gran6rus A-K. Survival time, mortality, and cause of death in elderly patients with Parkinson’s disease: a 9-year follow-up. Movement Disorders. 2003;18(11): 1312–1316.

11. Parkinson J. An essay on the shaking palsy. Journal of Neuropsychiatry and Clinical Neurosciences. 2002;14(2):223–236.

12. The 20th century mortality files, 1901–2000. Office for National Statistics. March 11, 2011. https://webarchive.nationalarchives.gov. uk/20150908090558; www.ons.gov.uk/ons/publications/ re-reference-tables.html?edition=tcm%3A77-215593. Accessed January 22, 2019; Duvoisin RC, Schweitzer MD. Paralysis agitans mortality in England and Wales, 1855–1962. British Journal of Preventive and Social Medicine. 1966;20(1):27–33.

13. More C. Understanding the Industrial Revolution. 1st ed. Routledge; 2000.

14. Ritchie H. What the history of London’s air pollution can tell us about the future of today’s growing megacities. Our World in Data. June 20, 2017. https://ourworldindata.org/london-air-pollution. Accessed December 12, 2018; Roser M, Ritchie H. Fertilizer and pesticides. Our World in Data. 2019. https://ourworldindata.org/fertilizer-and-pesticides. Accessed March 25, 2019; Manganese: history and industry development. Metalpedia. http://metalpedia.asianmetal. com/metal/ manganese/history.shtml. Accessed March 28, 2019; Bell T. The history of steel: From Iron Age to electric arc furnaces. The Balance. www. thebalance.com/steel-history-2340172. Updated June 25, 2019. Accessed March 28, 2019; Caudle WM, Guillot TS, Lazo CR, Miller GW. Industrial toxicants and Parkinson’s disease. Neurotoxicology. 2012;33(2):178–188.

15. Roser M, Ritchie H. Fertilizer and pesticides. Our World in Data. https:// ourworldindata.org/ fertilizer-and-pesticides. Accessed March 25, 2019.

16. Ascherio A, Chen H, Weisskopf MG, et al. Pesticide exposure and risk for Parkinson’s disease. Annals of Neurology. 2006;60(2): 197–203; Semchuk KM, Love EJ, Lee RG. Parkinson’s disease and exposure to agricultural work and pesticide chemicals. Neurology. 1992;42(7):1328–1328; Pezzoli G, Cereda E. Exposure to pesticides or solvents and risk of Parkinson disease. Neurology. 2013;80(22):2035–2041; Tanner CM, Kamel F, Ross GW, et al. Rotenone, paraquat, and Parkinson’s disease. Environmental Health Perspectives. 2011;119(6): 866–872.

17. Caudle WM, Guillot TS, Lazo CR, Miller GW. Industrial toxicants and Parkinson’s disease. Neurotoxicology. 2012;33(2):178–188; Betarbet R, Sherer TB, Greenamyre JT. Animal models of Parkinson’s disease. BioEssays. 2002;24(4):308–318; Uversky VN. Neurotoxicant-induced animal models of Parkinson’s disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration. Cell and Tissue Research . 2004;318(1):225–241.

18. Hogue C. Trump administration delays bans of toxic solvents. Chemical & Engineering News. December 20, 2017. https://cen.acs.org/articles/95/ web/2017/12/Trump-administration-delays-bans-toxic.html. Accessed March 28, 2019.

19. Barringer F. E.P.A. charts risks of a ubiquitous chemical. New York Times. September 30, 2011; Vettel P. Worried about decaf coffee? Fears are groundless. Chicago Tribune. May 19, 1985. www.chicagotribune. com/news/ct-xpm-1985-05-19-8502010068-story.html. Accessed July 19, 2019.

20. What is Superfund? US Environmental Protection Agency. www.epa. gov/superfund/what-superfund. Updated November 30, 2018. Accessed March 28, 2019.

21. Record of decision: Modock Road Springs/DLS Sand and Gravel, Inc. Site, Town of Victor, Ontario County, New York, Site Number 8-35-013. New York State Department of Environmental Conservation. January 2010. www.dec.ny.gov/docs/remediation_hudson_pdf/ 835013rod.pdf. Accessed March 29, 2019.